GE HealthCare Technologies CFO William K. Grogan Receives Equity Awards
GE HealthCare Technologies Inc.
Subscribe to track GEHC
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š GE HealthCare Technologies Inc. ($GEHC) Form 4 Filing Insider: Grogan William K (Chief Financial Officer) Transaction Date: September 14, 2026 Type: Equity Award / Grant (Code A) ⢠RSUs Granted: 75,096 shares @ $0.00 ⢠Stock Options Granted: 31,877 options (Exercise price: $64.25) ⢠Shares Owned Following Transactions: 75,096 Significance: Low (Routine annual/retention equity compensation)
Comprehensive Analysis
Insider Filing Analysis: GE HealthCare Technologies Inc. (NASDAQ: GEHC)
Executive Summary
On September 16, 2026, William K. Grogan, Chief Financial Officer of GE HealthCare Technologies Inc., reported receiving initial/periodic equity grants totaling 75,096 restricted stock units (RSUs) and 31,877 employee stock options with an exercise price of $64.25 per share, dated September 14, 2026.
Transaction Breakdown
- Restricted Stock Units (Grant 1): 62,256 RSUs vesting 50% on September 14, 2027, and 50% on September 14, 2028.
- Restricted Stock Units (Grant 2): 12,840 RSUs vesting 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029.
- Stock Options: 31,877 options with an exercise price of $64.25 per share, expiring September 14, 2036, vesting over three years (33% on Sept 2, 2027; 33% on Sept 2, 2028; 34% on Sept 2, 2029).
- Net Ownership Post-Transaction: 75,096 common shares (held via RSUs) directly.
Market & Governance Context
Because these transactions represent standard compensation grants awarded by the company at $0.00 direct cost to the insider rather than open-market purchases, they carry Low market signaling significance. However, they establish significant long-term performance alignment between the CFO and shareholders.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
